Draft Genome Sequence of VIM-2-Producing Multidrug-Resistant Pseudomonas aeruginosa ST175, an Epidemic High-Risk Clone. [artículo]
Por: Chaves Sánchez, Fernando [Microbiología y Parasitología]
| Rodríguez Otero, Joaquín [Microbiología y Parasitología] | Viedma Moreno, Esther [Instituto de Investigación i+12].
Colaborador(es): Instituto de Investigación imas12 | Servicio de Microbiología y Parasitología.
Editor: Genome announcements, 2013Descripción: 1(2):e0011213.Recursos en línea: Acceso libre Resumen: The VIM-2-producing multidrug-resistant high-risk clone Pseudomonas aeruginosa sequence type (ST) 175 was isolated in the setting of a large outbreak in Hospital Universitario 12 de Octubre (Spain) from 2007 to 2010. This strain was resistant to all beta-lactams, fluoroquinolones, and aminoglycosides, with the exception of amikacin, and has become an endemic clone in our institution.
| Tipo de ítem | Ubicación actual | Signatura | Estado | Fecha de vencimiento |
|---|---|---|---|---|
Artículo
|
PC5229 (Navegar estantería) | Disponible |
Formato Vancouver:
Viedma E, Juan C, Otero JR, Oliver A, Chaves F. Draft Genome Sequence of VIM-2-Producing Multidrug-Resistant Pseudomonas aeruginosa ST175, an Epidemic High-Risk Clone. Genome Announc. 2013 Apr 11;1(2):e0011213.
PMID: 23580706
Contiene 12 referencias
The VIM-2-producing multidrug-resistant high-risk clone Pseudomonas aeruginosa sequence type (ST) 175 was isolated in the setting of a large outbreak in Hospital Universitario 12 de Octubre (Spain) from 2007 to 2010. This strain was resistant to all beta-lactams, fluoroquinolones, and aminoglycosides, with the exception of amikacin, and has become an endemic clone in our institution.
No hay comentarios para este ejemplar.